Oncogenic deregulation of EZH2 as an opportunity for targeted therapy in lung cancer

Haikuo Zhang, Jun Qi, Jaime M. Reyes, Lewyn Li, Prakash K. Rao, Fugen Li, Charles Y. Lin, Jennifer A. Perry, Matthew A. Lawlor, Alexander Federation, Thomas De Raedt, Yvonne Y. Li, Yan Liu, Melissa A. Duarte, Yanxi Zhang, Grit S. Herter-Sprie, Eiki Kikuchi, Julian Carretero, Charles M. Perou, Jacob B. ReibelJoshiawa Paulk, Roderick T. Bronson, Hideo Watanabe, Christine Fillmore Brainson, Carla F. Kim, Peter S. Hammerman, Myles Brown, Karen Cichowski, Henry Long, James E. Bradner, Kwok Kin Wong

Research output: Contribution to journalArticlepeer-review

94 Scopus citations

Fingerprint

Dive into the research topics of 'Oncogenic deregulation of EZH2 as an opportunity for targeted therapy in lung cancer'. Together they form a unique fingerprint.

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science